InsidersTradesSigma
Browse the complete record of transactions filed by Calabrese Salvatore, Chief Financial Officer. Officer active across 1 company, notably Gain Therapeutics, Inc.. Aggregated, 2 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €23m. Activity tracked since 19 May 2022. The latest transaction was filed on 19 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Calabrese Salvatore is the Chief Financial Officer of Gain Therapeutics, Inc. He is responsible for the financial management of the company, including financial planning and risk management. His role is essential in ensuring the financial health of the company and supporting its growth initiatives.